Bivalirudin for injection
WebDec 15, 2024 · Bivalirudin (with or without prior unfractionated heparin) is recommended by the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), and the Society for Cardiovascular Angiography and Interventions (SCAI) as an appropriate choice of anticoagulant for this use. Webbivalirudin for injection - ADD-VANTAGE Quick Finder Pfizer samples (for eligible HCPs) Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426or by visiting the PfizerPro website www.pfizerpro.com. Report an adverse event or concern about the quality of a Pfizer product
Bivalirudin for injection
Did you know?
WebBivalirudin Injection is an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI). 2 DOSAGE AND ADMINISTRATION . 2.1 Recommended Dosage . The recommended dose of Bivalirudin Injection is an intravenous bolus dose of 0.75 mg/kg, followed immediately by a maintenance infusion of 1.75 mg/kg/h for the … WebBivalirudin exhibits linear pharmacokinetics following IV administration to patients undergoing PTCA. In these patients, a mean steady state bivalirudin concentration of 12.3 ± 1.7 mcg/mL is achieved following an IV bolus of 1 mg/kg and a 4-hour 2.5 mg/kg/h IV infusion. Distribution. Bivalirudin does not bind to plasma proteins (other than ...
WebJan 18, 2024 · Bivalirudin for injection is a direct thrombin inhibitor used as an anticoagulant for the following patients: 1. Percutaneous transluminal coronary angioplasty (PTCA): For patients undergoing... WebApr 15, 2024 · Bivalirudin for injection is indicated for use as an anticoagulant for use in patients undergoing percutaneous coronary intervention (PCI) including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. 2 DOSAGE AND ADMINISTRATION 2.1 Recommended Dosage
WebBivalirudin drug products are used in patients as an anticoagulant. USP's Biologics Monographs 1 Expert Committee has collaborated with multiple US-approved sponsors to develop two new monographs, Bivalirudin and Bivalirudin for Injection. WebBivalirudin is intended for intravenous bolus injection and continuous infusion after reconstitution and dilution. Preparation Instructions for Bolus Injection and Continuous …
WebSep 15, 2024 · Bivalirudin for Injection is supplied as a sterile white lyophilized cake, in single-dose vials. Each vial contains 250 mg bivalirudin, equivalent to an average of 270 mg of bivalirudin …
WebBivalirudin for Injection. Single-dose ADD-Vantage® Vial. AVAILABILITY* Image filed. UoS† NDC. CONCENTRATION. CONTENT. PRODUCT INFORMATION‡§ ... bing aifacebookWeb2.1 Recommended Dosage - Bivalirudin has been studied only in patients receiving concomitant aspirin. The recommended dose of bivalirudin is an intravenous bolus dose of 0.75 mg/kg, followed ... 3 DOSAGE FORMS AND STRENGTHS For injection: 250 mg of bivalirudin as a lyophilized powder in a single-dose, ADD-Vantage™ vial for reconstitution. cytochrome c proteinWebBivalirudin for Injection. Overview. Presentation(s): 250 mg NDC(s): 55150-0210-10 Reference Listed Drug: Angiomax® Therapeutic Class: Anticoagulant Physical Form: Powder Back to All Products Download … bing ai for mac osbing ai featureWebFeb 1, 2024 · Bivalirudin is a prescription medication used to treat heparin-induced thrombocytopenia (HIT) and heparin-induced thrombocytopenia and thrombosis (HITT). Drugs & Vitamins ... Injection, powder for reconstitution. 250mg/vial; Injection, ready-to-use solution. 5mg/mL (250mg/50mL; 500mg/100mL) bing ai fix codeWebNov 5, 2024 · ANGIOMAX RTU- bivalirudin injection, solution MAIA Pharmaceuticals, Inc. 1 INDICATIONS AND USAGE ANGIOMAX RTU is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI), including patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and … bing ai for chromeWebFor injection: 250 mg of bivalirudin as a lyophilized powder in a single-dose vial for reconstitution. Each vial contains 250 mg of bivalirudin equivalent to an average of 275 mg bivalirudin trifluoroacetate*. *The range of bivalirudin trifluoroacetate is 270 to 280 mg based on a range of trifluoroacetic acid composition of 1.7 to . 2.6 ... cytochrome c solubility